Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080003226A1
SERIAL NO

11570033

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns a method to prevent or reduce adverse effects on liver of a patient treated with a Fas-mediated apoptosis-inducing agent, the method comprising the administration of a product preventing TNF receptors-mediated apoptosis of the liver cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APOXIS SA22 CHEMIN DES CROISETTES EPALINGES 1066

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Demotz, Stephane Epalinges, CH 5 5
Dupuis, Marc Blonay, CH 5 6
Goedkoop, Rene Bogis Bossey, CH 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation